New genetic link to high blood pressure found

October 17, 2005

ANN ARBOR, Mich. -- A new genetic discovery made by a University of Michigan team may help explain why some people develop high blood pressure and others don't -- and why some people's blood pressure increases as they age.

It also gives new insight into how the kidneys govern the balance of salt in the body, a crucial task for regulating blood pressure. And, it reveals how a gene already linked to behavior and mental health can play a role in the body, as well as the brain.

In a paper published in the American Journal of Hypertension, U-M researchers report that blood pressure was higher, and more likely to rise with age, among people who had an extra-long form of a gene called DRD4.

They made the discovery by studying the genes of 864 people from 286 families taking part in a long-term blood pressure genetics study called GenNet. The families all live in or near the town of Tecumseh, Mich., which since 1958 has been home to a U-M clinical research initiative called the Tecumseh Community Health Study.

The finding of a link between DRD4 and blood pressure came as a surprise to researchers who tested this gene initially to look at genetics and behavior.

Cells use the DRD4 gene to make a receptor for a chemical called dopamine, which transmits messages between cells. Dopamine is best known for its role in the brain, where it is involved in feelings of pleasure, and in governing movement. Some studies have suggested that variations in genes for dopamine receptors are linked to certain behavioral traits or personality types.

But in recent years dopamine has also been found to play a role in regulating the release of salt by the kidneys. The new U-M finding adds more evidence for that role.

"While many genes are involved in blood pressure and the inherited risk of developing hypertension, we're learning that variations in genes for dopamine receptors play a significant role," says senior author Alan Weder, M.D., professor of internal medicine at the U-M Medical School. "As we learn more, we may be able to determine which patients need the most aggressive blood pressure treatment, and to develop drugs that can lower blood pressure by intervening directly in the proximal tubules of the kidneys, where dopamine acts -- something today's drugs don't do."

The new study is the first to show that the DRD4 receptor plays a role in the regulation of blood pressure by the kidneys, and to show that a common variation in the gene is associated with higher blood pressure. Two other dopamine receptors have previously been shown to be linked to blood pressure regulation.

One in four American adults has high blood pressure, also called hypertension -- and many don't know it. If high blood pressure isn't lowered with the help of diet, exercise and medication, it can dramatically raise the risk of heart attack, stroke or kidney problems.

Blood pressure is expressed in two numbers, one on top of the other, that measure the pressure of blood traveling in blood vessels, both during and between heartbeats. The top number is the "systolic" blood pressure, and the bottom number is the "diastolic" blood pressure. Pressures are measured in millimeters of mercury, or mm Hg. People are considered to have high blood pressure if their blood pressure is greater than 140 mm Hg systolic, or 90 mm Hg diastolic.

Blood pressure, especially the systolic pressure, tends to rise as a person gets older. And in older people, high systolic pressure is considered the greatest risk factor for cardiovascular disease.

That's one reason the new finding is especially significant, says Weder, who directs the Tecumseh and GenNet studies and is a member of the U-M Cardiovascular Center. "This gene variation may be useful in developing a predictor of which patients are likely to have a rapid rise in blood pressure as they age, and may need more aggressive monitoring and treatment," he says. However, he and his co-authors say, no one gene variation is enough to predict an individual person's blood pressure tendencies, and further research on the genes involved in hypertension will be needed.

The other important implication of the finding is to create a fuller understanding of dopamine's action in the kidneys, and changes in that action brought about by variations in the receptor gene. Dopamine in the kidney helps the body respond to large loads of sodium, or salt, coming into the body. After a salty meal, for example, higher levels of dopamine can be detected in the urine after being produced and used by the kidneys to regulate the removal of salt from the body.

Problems or perturbations anywhere in the system that produces dopamine or receives its signals on the cell surface could alter someone's ability to regulate sodium levels, and therefore blood pressure, Weder explains.

The new finding is published by a team that includes Weder and his Tecumseh study team -- but also researchers whose specialties are psychiatry and the genetics of human behavior. Co-author Margit Burmeister, Ph.D., a geneticist in the Molecular & Behavioral Neurosciences Institute, explains how the unusual pairing came about.

"We wanted to do a population-based study of genes associated with personality and behavioral traits, and were able to work with Alan to survey the Tecumseh study participants for such traits," she explains. The genotyping was done by her laboratory team, led by Srijan Sen, M.D., Ph.D., a Medical Scientist Training Program graduate now at Yale University.

Burmeister and her U-M colleague, psychiatry professor Randolph Nesse, M.D., set out to look at whether variations in genes such as DRD4 were associated with any particular behavioral traits, such as attention problems or a novelty-seeking personality type -- links suggested by other researchers.

They didn't find any significant association with those traits. But when Weder asked if they could cross-reference blood pressure and gene variations, they turned up the link to variations in DRD4. Specifically, the analysis shows that people with a repeated stretch of duplicate DNA within one copy of their DRD4 gene -- the "long" form of the gene -- tended to have blood pressures that were several points higher than those with the shorter form of the gene.

Weder notes that the surprising blood pressure-DRD4 findings could only have come about through collaboration between blood pressure specialists and behavioral geneticists. "We did not expect to have this result, because DRD4 is not considered a standard hypertension gene," he says. "But when you don't know what the genes are, you just have to take your best shot and throw a wide net."

Now that the net has been cast, he adds, he and his colleagues will continue to look at the genes for other dopamine receptors and see if there are any ties with blood pressure traits and trends. Meanwhile, Burmeister plans to continue to look at the Tecumseh study DNA samples and behavioral survey data for other possible relationships.
-end-
In addition to Weder, Burmeister, Sen and Nesse, the paper is co-authored by research fellow Li Sheng, Ph.D., former postdoctoral fellow Scott Stoltenberg, now at Black Hills State University, and internal medicine research investigator Lillian Gleiberman, Ph.D. Burmeister is a professor in the U-M Medical School's departments of Psychiatry and Human Genetics. Nesse also holds positions in the Department of Psychology in the U-M College of Literature, Science and the Arts, and in the U-M Institute for Social Research.

The study was supported by the Nancy Pritzker Depression Research Network, the Michigan Society of Fellows, the Rachel Upjohn Clinical Scholars Program, and the National Heart, Lung and Blood Institute, which funds the GenNet study as part of the Family Blood Pressure Program.

Reference: American Journal of Hypertension, (18) 9, September 2005, pp. 1206-1210

University of Michigan Health System

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.